| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
RTW Venture Fund welcomes IPO of portfolio company Biomea Fusion
StockMarketWire.com
|
Biopharmaceutical and medical technology investor RTW Venture Fund welcomed news that portfolio company Biomea Fusion had priced a $153 million initial public offering in the US.
Biomea was a preclinical-stage biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers.
Its IPO raised $153 million by offering 9 million shares at $17.00 per share.
On the first day of trading, Biomea's share price increased 9.4% to close at $18.11.
At 8:50am: (LON:RTW) share price was 0p at 1.69p
Story provided by StockMarketWire.com
|
|
|
|
|
|
